Story
1 Mär 2005
GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing
Alle Tags anzeigen
Alle Tags anzeigen
Abbott Laboratories
AstraZeneca
Amgen
Bristol-Myers Squibb
Chiron
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Merck Sharp & Dohme (part of Merck)
Novartis
Pfizer
Procter & Gamble
Roche
Ranbaxy Laboratories
Schering-Plough
Shire
Tibotec (part of Johnson & Johnson)
Wyeth (part of Pfizer)
Janssen Pharmaceutica (part of Johnson & Johnson)
Medikamentenzugang
Krankheit
Geistiges Eigentum
Reputation
OECD-Richtlinien
Leitlinien formuliert von Regierungen
G7
WHO
EU und EU-Parlament
Weltbank
Welthandelsorganisation (WTO)
Personal Health
Trade
Company Reporting
Company Support for Initiatives Promoting Development, Economic and Social Rights